HealthStar names Muratore to succeed Levy
HealthStar has named Bob Muratore as Levy's successor, giving him the new title group president of agency services. Muratore also serves as executive vice president of corporate planning at HealthStar.
The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.
The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.
The company plans to spin off its pharmaceutical unit.